Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis
- PMID: 31194767
- PMCID: PMC6563955
- DOI: 10.1371/journal.pone.0216697
Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis
Abstract
Background: Recurrent Respiratory Papillomatosis (RRP) is a rare disease characterized by the growth of papillomas in the airway and especially the larynx. The clinical course is highly variable among individuals and there is poor understanding of the factors that drive an aggressive vs an indolent course.
Methods: A convenience cohort of 339 affected subjects with papillomas positive for only HPV6 or HPV11 and clinical course data available for 1 year or more, from a large multicenter international study were included. Exploratory data analysis was conducted followed by inferential analyses with frequentist and Bayesian statistics.
Results: We examined 339 subjects: 82% were diagnosed prior to the age of 18 years, 65% were infected with HPV6, and 69% had an aggressive clinical course. When comparing age at diagnosis with clinical course, the probability of aggressiveness is high for children under five years of age then drops rapidly. For patients diagnosed after the age of 10 years, an indolent course is more common. After accounting for confounding between HPV11 and young age, HPV type was minimally associated with aggressiveness. Fast and Frugal Trees (FFTs) were utilized to determine which algorithms yield the highest accuracy to classify patients as having an indolent or aggressive clinical course and consistently created a branch for diagnostic age at ~5 years old. There was no reliable strong association between clinical course and socioeconomic or parental factors.
Conclusion: In the largest cohort of its type, we have identified a critical age at diagnosis which demarcates a more aggressive from less aggressive clinical course.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures



Similar articles
-
Clinical course of recurrent respiratory papillomatosis: comparison between aggressiveness of human papillomavirus-6 and human papillomavirus-11.Head Neck. 2015 Nov;37(11):1625-32. doi: 10.1002/hed.23808. Epub 2014 Sep 12. Head Neck. 2015. PMID: 24955561
-
Risk factors for aggressive recurrent respiratory papillomatosis in adults and juveniles.PLoS One. 2014 Nov 24;9(11):e113584. doi: 10.1371/journal.pone.0113584. eCollection 2014. PLoS One. 2014. PMID: 25419846 Free PMC article.
-
Human papillomatosis genotyping and severity in patients with recurrent respiratory papillomatosis.J Med Assoc Thai. 2014 Jun;97 Suppl 6:S136-41. J Med Assoc Thai. 2014. PMID: 25391185
-
Recurrent respiratory papillomatosis: A state-of-the-art review.Respir Med. 2017 May;126:116-121. doi: 10.1016/j.rmed.2017.03.030. Epub 2017 Apr 1. Respir Med. 2017. PMID: 28427542 Review.
-
The role of HPV type in Recurrent Respiratory Papillomatosis.Int J Pediatr Otorhinolaryngol. 2010 Jan;74(1):7-14. doi: 10.1016/j.ijporl.2009.09.004. Epub 2009 Oct 1. Int J Pediatr Otorhinolaryngol. 2010. PMID: 19800138 Review.
Cited by
-
Clinical implications of alpha, beta, and gamma HPV infection in juvenile onset recurrent respiratory papillomatosis.Eur Arch Otorhinolaryngol. 2022 Jan;279(1):285-292. doi: 10.1007/s00405-021-07040-9. Epub 2021 Aug 28. Eur Arch Otorhinolaryngol. 2022. PMID: 34453571 Free PMC article.
-
Histological Severity Risk Factors Identification in Juvenile-Onset Recurrent Respiratory Papillomatosis: How Immunohistochemistry and AI Algorithms Can Help?Front Oncol. 2021 Mar 8;11:596499. doi: 10.3389/fonc.2021.596499. eCollection 2021. Front Oncol. 2021. PMID: 33763347 Free PMC article.
-
High recurrence rate in patients with juvenile-onset respiratory papillomatosis and its risk factors.Eur Arch Otorhinolaryngol. 2022 Aug;279(8):4061-4068. doi: 10.1007/s00405-022-07390-y. Epub 2022 Apr 20. Eur Arch Otorhinolaryngol. 2022. PMID: 35441895
-
An updated review of the epidemiological factors associated with recurrent respiratory papillomatosis.Laryngoscope Investig Otolaryngol. 2021 Jan 28;6(2):226-233. doi: 10.1002/lio2.521. eCollection 2021 Apr. Laryngoscope Investig Otolaryngol. 2021. PMID: 33869755 Free PMC article. Review.
-
Outcomes After Human Papillomavirus Vaccination in Patients With Recurrent Respiratory Papillomatosis: A Nonrandomized Clinical Trial.JAMA Otolaryngol Head Neck Surg. 2022 Jul 1;148(7):654-661. doi: 10.1001/jamaoto.2022.1190. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 35653138 Free PMC article. Clinical Trial.
References
-
- Cuello G, Sánchez GI, Jaramillo R, Quintero K, Baena A, O’Byrne A, et al. Clinical characteristics and HPV type in recurrent respiratory papillomatosis in Colombia. Salud Publica Mex. 2013;55: 416–420. - PubMed
Publication types
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources